By David Lindberg, Chief Executive Officer — Hanobi Peptides™
Data integrity is often discussed as a downstream concern—something to be protected during analysis, interpretation, or publication. In reality, data integrity is established much earlier. In peptide research, it begins with how materials are tested before they ever reach the lab.
In-house testing plays a critical role in safeguarding that integrity.
Proximity Between Production and Analysis
When analytical testing is performed in-house, it exists in close proximity to synthesis and purification. This proximity matters. It allows manufacturing and analytical teams to communicate directly, align expectations, and respond quickly to deviations.
Questions about a batch can be addressed immediately, with full access to production context. There is no need to infer conditions or rely on secondhand explanations. This immediacy reduces the risk of misinterpretation and strengthens confidence in the data produced.
Data integrity benefits when testing is not separated from process.
Consistency Through Controlled Methods
In-house testing enables manufacturers to apply analytical methods consistently over time. Instrumentation, protocols, and interpretation standards are maintained within a single quality framework.
When testing is fragmented across external laboratories, subtle differences in method execution or reporting can introduce variability. Even when external labs are competent, alignment across batches can be difficult to sustain.
Consistency in testing supports consistency in data—and consistency is the backbone of integrity.
Faster Identification of Deviations
Analytical testing is most valuable when it functions as an early warning system. In-house testing allows deviations to be identified and investigated before materials are released.
When anomalies appear, teams can trace them back through synthesis, purification, and handling without delay. This rapid feedback loop enables corrective action at the source rather than retrospective explanation after materials have been distributed.
Preventing questionable data from entering the research pipeline protects everyone involved.
Contextual Interpretation of Results
Analytical results do not exist in isolation. Their meaning is shaped by knowledge of the manufacturing process. In-house teams possess that knowledge inherently.
This context allows results to be interpreted with nuance. Minor variations can be evaluated accurately rather than over- or underemphasized. Decisions about release, reprocessing, or rejection are made with full understanding of their implications.
Data integrity depends not only on measurement, but on informed interpretation.
Transparency Without Translation Loss
When testing is internal, documentation reflects direct observation rather than summarized reports. Data does not need to be translated between organizations, reducing the risk of omission or simplification.
This transparency improves the quality of Certificates of Analysis and supporting records. Researchers receive documentation that is closer to the source, both technically and philosophically.
Clear lineage between testing and documentation strengthens trust.
Accountability Is Clear
In-house testing clarifies accountability. When the same organization is responsible for production and analysis, ownership of data is unambiguous.
This accountability drives discipline. Results cannot be deflected or externalized. Standards must be upheld consistently because responsibility cannot be transferred.
Data integrity thrives in environments where accountability is clear.
Supporting Researchers Through Reliability
Researchers may never see the internal systems that support data integrity, but they experience the outcome. Materials behave predictably. Documentation aligns with performance. Results are easier to interpret and defend.
In-house testing contributes directly to this reliability by ensuring that data reflects reality rather than assumption.
At Hanobi Peptides™, we view in-house testing as an essential component of research support. It allows us to stand behind our data with confidence and provide researchers with materials they can trust.
Integrity Is Built Into the Process
Data integrity is not achieved through declarations or disclaimers. It is built through systems that prioritize accuracy, consistency, and accountability.
In-house testing strengthens those systems by keeping measurement, interpretation, and responsibility aligned.
In peptide science, integrity begins long before data is published.
It begins with how materials are tested—and who takes responsibility for the results.